| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
1.17 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
NKX2-5 |
NKX2-5, CSX, NKX2.5, NKX2E: Homeobox protein Nkx-2.5 |
1.17 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
1.17 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
1.17 |
Evidence |
|
| SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
1.17 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
GMIP |
GMIP: GEM-interacting protein |
1.17 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
DYRK3 |
IPI00465460 |
1.17 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
1.17 |
Evidence |
|
| TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
DLG1 |
IPI00218729 |
1.17 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
1.17 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
HDAC5 |
HDAC5, KIAA0600: Histone deacetylase 5 |
1.17 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
1.17 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
SHC1 |
SHC1, RP11-307C12.1-001, hCG_1997126: SHC |
1.17 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.17 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.17 |
Evidence |
|
| MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
SSH1 |
SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 |
1.17 |
Evidence |
|
| BCKDHA |
BCKDHA: 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial precursor |
PDK1 |
PDK1: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precu |
1.17 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
TSHR |
IPI00386365 |
1.17 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
1.17 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.17 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
RYR1 |
|
1.17 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.17 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.17 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.17 |
Evidence |
|
| MAFG |
MAFG: Transcription factor MafG |
NFE2L2 |
NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 |
1.17 |
Evidence |
O
|